SCHEMBL6537792

SCHEMBL6537792

Cc1cnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc2c1OCc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.43
KMT2A Q03164 2/20 0.43
EPHB3 P54753 1/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
PPIA P62937 1/20 0.40
NPC1 O15118 2/20 0.40
HPGD P15428 2/20 0.40
RAB9A P51151 2/20 0.40
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
SENP5 Q96HI0 1/20 0.39
SENP2 Q9HC62 1/20 0.39
SENP1 Q9P0U3 1/20 0.39
SLC16A3 O15427 1/20 0.39
TYK2 P29597 3/20 0.39
MAPT P10636 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
JAK2 O60674 2/20 0.39
JAK1 P23458 1/20 0.39
TRPM4 Q8TD43 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6536777 0.87 GAA (0.43) KMT2ASMN1; SMN2HPGDRAB9AKDM4E
SCHEMBL6538032 0.87 THRB (0.47) KMT2ASMN1; SMN2NPC1RAB9ASLC16A3
SCHEMBL6538153 0.85 PTGES (0.41) KMT2ASMN1; SMN2RAB9AKDM4EALDH1A1
SCHEMBL6537592 0.85 KMT2A (0.44) KMT2ASMN1; SMN2TYK2MAPTJAK2
SCHEMBL6536825 0.84 MEN1 (0.42) KMT2ASMN1; SMN2NPC1TYK2JAK2
SCHEMBL6538019 0.84 ALDH1A1 (0.40) KMT2ASMN1; SMN2NPC1HPGDRAB9A
SCHEMBL6538027 0.84 SMN1; SMN2 (0.39) GHSRKMT2ASMN1; SMN2NPC1HPGD
SCHEMBL6538025 0.84 SMN1; SMN2 (0.39) GHSRKMT2ASMN1; SMN2NPC1HPGD
SCHEMBL6537706 0.82 TYK2 (0.41) KMT2ASMN1; SMN2RAB9AKDM4ETYK2
SCHEMBL6538123 0.82 SMN1; SMN2 (0.41) KMT2ASMN1; SMN2NPC1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed